# Dexcel Pharma Ltd. – FDA Inspection, Jul 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/22fbe152-1d95-4a72-a2b9-b19e079e4ac5
Source feed: FDA_Inspections

> FDA inspection 1097285 of Dexcel Pharma Ltd., July 24, 2019. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097285
- Company Name: Dexcel Pharma Ltd.
- Inspection Date: 2019-07-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1195631 - 2022-12-14
- [FDA Inspection 1007877 - 2017-02-16](https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/cfef2ab3-f0eb-4b7b-bb92-e3ec84498568)
- FDA Inspection 836838 - 2013-06-05

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivis-l-negron-torres/eb77f360-bb0b-4a13-a0da-b89c36ccaca9)
- [FDA Associated Person](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)

Company: https://www.keypedia.com/companies/dexcel-pharma-ltd/4ec8aec2-8e4a-4886-8b52-f6d83c19e0c8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c